Surfactant Administration During Pediatric Cardiac Extracorporeal Membrane Oxygenation

Area of Science:

• Pediatric Cardiology
• Critical Care Medicine
• Respiratory Physiology

Background:

• Extracorporeal membrane oxygenation (ECMO) is a life-support measure for children with severe cardiac or respiratory failure.
• Surfactant therapy is crucial for neonatal respiratory distress syndrome but its role in pediatric cardiac ECMO is less defined.
• Assessing surfactant's safety and efficacy in this specific population is essential for optimizing treatment strategies.

Purpose of the Study:

• To evaluate the safety and efficacy of surfactant administration in pediatric patients undergoing ECMO for cardiac disease.
• To compare pulmonary compliance and respiratory distress severity scores between surfactant-treated and control groups.
• To identify any adverse events associated with surfactant use in this cohort.

Main Methods:

• A comparative study of pediatric cardiac ECMO patients, divided into a surfactant group (n=29) and a control group (n=51).
• Surfactant was administered to patients with lung compliance <0.5 ml/kg/cm H2O.
• Efficacy was assessed by changes in pulmonary compliance and radiography-based respiratory distress severity (RDS) scores at predefined time points.

Main Results:

• The surfactant group showed significant improvements in lung compliance (0.36 to 0.5 ml/kg/cm H2O, p=0.002) and RDS scores (13 to 12, p=0.04) post-decannulation.
• No cases of pneumothorax were observed in the surfactant group; mild pulmonary hemorrhage occurred in one patient in each group.
• Hospital duration and survival rates were comparable between the surfactant and control groups (69% vs. 78% survival).

Conclusions:

• Surfactant administration appears to be safe in pediatric cardiac ECMO patients, with no increased risk of pneumothorax.
• The findings suggest a potential benefit of surfactant in improving pulmonary compliance and respiratory distress in this population.
• Further research in larger cohorts is warranted to confirm these preliminary findings on surfactant efficacy in pediatric cardiac ECMO.